Association between salivary microbiota-related amino acid metabolic dysregulation and tacrolimus-induced gingival overgrowth following kidney transplantation.

Xuyu Xiang, Yi Zhu, Tianyin Wang, Ke Cheng, Yingzi Ming

Abstract read

In one paragraph

Article in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xuyu Xiang *The Transplantation Center of the Third Xiangya Hospital, Central South University, Changsha, China.

Yi Zhu *The Transplantation Center of the Third Xiangya Hospital, Central South University, Changsha, China.

Tianyin WangThe Transplantation Center of the Third Xiangya Hospital, Central South University, Changsha, China.

Ke ChengThe Transplantation Center of the Third Xiangya Hospital, Central South University, Changsha, China.

Yingzi MingThe Transplantation Center of the Third Xiangya Hospital, Central South University, Changsha, China. mingyz_china@csu.edu.cn.

Funding

National Natural Science Foundation of China 81771722

6 · The paper itself

Abstract

backgroundKidney transplant (KT) recipients require lifelong immunosuppressive therapy to prevent allograft rejection. Drug-induced gingival overgrowth (DIGO) is a notable adverse effect of tacrolimus, for which effective preventive or therapeutic strategies are lacking. Dysbiosis of the oral microbiota has been implicated as a major risk factor for DIGO. However, its mechanistic role remains poorly understood.

resultsTwenty KT recipients with newly diagnosed DIGO while receiving tacrolimus were enrolled, along with 20 matched controls with stable graft function. Salivary samples were collected and subjected to metagenomic and untargeted metabolomic profiling. Taxonomic analysis revealed greater microbial heterogeneity in DIGO patients compared to more interconnected communities observed in controls. Periodontitis-associated taxon, including Porphyromonas gingivalis, were enriched in the DIGO group. Multiple differentially expressed microbial genes and metabolites were identified, predominantly enriched in disordered amino acid metabolic pathways. Key metabolites-such as L-proline, carnosine, choline, 5-aminolevulinic acid, and spermidine-showed strong associations with DIGO-related taxon.

conclusionA strong association was observed between salivary microbial composition, metabolic profiles, and DIGO. The identified microbiota and metabolite alterations suggest a potential link between amino acid metabolic dysregulation and gingival fibroblast-related pathways in DIGO. These findings provide new insights into the biological features of DIGO and offer a foundation for future mechanistic and therapeutic studies.

Indexed as

Amino AcidsGingival OvergrowthImmunosuppressive AgentsKidney TransplantationMicrobiotaSalivaTacrolimusAdultCase-Control StudiesFemaleHumansMaleMiddle AgedAmino AcidsImmunosuppressive AgentsTacrolimusCase–controlKidney transplantMetabolomic sequencingMetagenomic sequencingSalivary microbiotaTacrolimus-induced gingival overgrowth

Identifiers

PMID42410398

DOI10.1186/s12903-026-09004-z

PMCPMC13621746

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.